» Articles » PMID: 8554775

The Aberrant Behavior Checklist-Community: Factor Validity and Effect of Subject Variables for Adults in Group Homes

Overview
Specialty Psychiatry
Date 1995 Nov 1
PMID 8554775
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The factor validity of the new Aberrant Behavior Checklist-Community (ABC-C) was determined with 1,040 group home residents. Exploratory factor analysis indicated that the factor structure derived from the original ABC appears to be valid for the ABC-C when used with this population. Coefficients of congruence showed a high level of concordance with the original factor structure, and internal consistency continued to be high for each of the five subscales. Analyses for the effects of age, gender, and level of mental retardation indicated that some correction is appropriate for each of these variables when scoring the ABC-C. Further analyses explored the effects of subjects variables such as visual and auditory handicaps and the presence of epilepsy or Down syndrome. Psychotropic medication use was often associated with subscale score differences. The original ABC factor structure appears valid for scoring the ABC-C with community-based adults, at least those living in group homes.

Citing Articles

High-Dose Propranolol for Severe and Chronic Aggression in Autism Spectrum Disorder: A Pilot, Double-Blind, Placebo-Controlled, Randomized Crossover Study.

London E, Zimmerman-Bier B, Yoo J, Gaffney J J Clin Psychopharmacol. 2024; 44(5):462-467.

PMID: 39174017 PMC: 11460740. DOI: 10.1097/JCP.0000000000001895.


Contextual Variables Associated with Challenging Behaviors in Adolescents with Fragile X Syndrome.

Brady N, Fleming K, Hicks T, Fielding-Gebhardt H, Boorom O J Autism Dev Disord. 2024; .

PMID: 39102069 DOI: 10.1007/s10803-024-06497-x.


Integrative Care for Challenging Behaviors in People with Intellectual Disabilities to Reduce Challenging Behaviors and Inappropriate Psychotropic Drug Prescribing Compared with Care as Usual: A Cluster-Randomized Trial.

de Kuijper G, Jonker J, Kouwer K, Hoekstra P, de Bildt A Int J Environ Res Public Health. 2024; 21(7).

PMID: 39063526 PMC: 11277020. DOI: 10.3390/ijerph21070950.


Cognitive-Behavioral Profile in Pediatric Patients with Syndrome 5p-; Genotype-Phenotype Correlationships.

Bel-Fenellos C, Biencinto-Lopez C, Saenz-Rico B, Hernandez A, Sandoval-Talamantes A, Tenorio-Castano J Genes (Basel). 2023; 14(8).

PMID: 37628679 PMC: 10454038. DOI: 10.3390/genes14081628.


Statins for Smith-Lemli-Opitz syndrome.

Ballout R, Livinski A, Fu Y, Steiner R, Remaley A Cochrane Database Syst Rev. 2022; 11:CD013521.

PMID: 36373961 PMC: 9661876. DOI: 10.1002/14651858.CD013521.pub2.